146 filings
Page 3 of 8
6-K
kzqqs
9 Dec 21
BrainsWay Announces Publication of Deep TMS™ Trial Results for Reduction of Heavy Drinking in Alcohol-Dependent Subjects
7:30am
6-K
2d9m4
17 Nov 21
Current report (foreign)
4:01pm
6-K
jg4j4kh
17 Nov 21
BrainsWay Reports Third Quarter 2021 Financial Results and Operational Highlights
7:30am
EFFECT
cdh3kfbes 89ybfg1n
12 Oct 21
Notice of effectiveness
12:15am
CORRESP
p4r9x
6 Oct 21
Correspondence with SEC
12:00am
UPLOAD
ckmrr4f1
4 Oct 21
Letter from SEC
12:00am
F-3
8ujw p0nn3cwpba
17 Sep 21
Shelf registration (foreign)
4:06pm
6-K
7ee6r 69ys
18 Aug 21
Current report (foreign)
7:30am
6-K
wmemjvb8 rs
11 Aug 21
BrainsWay Reports Second Quarter 2021 Financial Results and Operational Highlights
8:00am
UPLOAD
a1bzgleu o4bhx
23 Jun 21
Letter from SEC
12:00am
20-F/A
um828d7 fd1iu
17 Jun 21
Annual report (foreign) (amended)
5:00pm
CORRESP
v0hku
17 Jun 21
Correspondence with SEC
12:00am
UPLOAD
ew5tstph
7 Jun 21
Letter from SEC
12:00am
6-K
8uern 7sox
3 Jun 21
Current report (foreign)
9:30am
SC TO-I/A
yf7w8sk
3 Jun 21
Issuer tender offer statement (amended)
9:28am
6-K
62d 8eh50d7j2ccy1g
2 Jun 21
BrainsWay Announces Positive OCD Coverage Policy by Blue Cross Blue Shield® Licensee HCSC
8:00am
6-K
q26nc8f1aeu
1 Jun 21
BrainsWay Announces First Draft Proposal for OCD Coverage by a Regional Medicare Administrative Contractor
8:00am
6-K
fqrskr 1vkb
24 May 21
Current report (foreign)
8:00am
6-K
12nc7
24 May 21
BrainsWay Updates Line Item in 2021 First Quarter Financial Results
7:30am
6-K
m3t6g
20 May 21
BrainsWay Reports First Quarter 2021 Financial Results and Operational Highlights
8:00am